According to the literature, there is some evidence that patients in whom DLBCL is CD10 positive (GCB type) and who have a high MUM-1 expression in >50% of lymphoma cells have a worse prognosis, similar to the prognosis of the ABC subtype [18]. This evidence concerns the gene MME and diffuse large B-cell lymphoma.